South Carolina Board of Pharmacy: New Contract Manufacturer Permit and 503B Regulatory Updates

The South Carolina Board of Pharmacy has introduced significant regulatory changes affecting two distinct groups in the pharmaceutical supply chain: contract manufacturers and 503B outsourcing facilities.

Both sets of changes stem from the updated regulations published in the South Carolina State Register in May 2026, and both carry near-term compliance deadlines that organizations should act on now.

New Nonresident Contract Manufacturer Permit Requirement

South Carolina now requires a nonresident contract manufacturer/repackager permit for any out-of-state entity that manufactures, packages, repackages, labels, or relabels drugs or devices to another company's specifications for distribution into the state.

This is a new and distinct permit category. Contract manufacturers that also hold the NDA, ANDA, or unique device identification for a product they produce are not exempt. They must obtain a separate manufacturer/repackager permit in addition to the contract manufacturer permit.

The requirement applies to both domestic and international entities. At a minimum, non-resident manufacturers and contract manufacturers must have been inspected by the FDA to qualify for a permit in South Carolina.

Application deadline: June 30, 2027. Facilities engaged in contract manufacturing must submit an application prior to this date.

Action Required by October 5, 2026

Facilities that already hold a South Carolina permit and that only engage in contract manufacturing must email the Board by October 5, 2026 with the following information:

• Facility name
• Permit number
• A brief description of business activities conducted

The Board will update the existing permit to reflect the new contract manufacturer permit type. Failure to notify the Board by this deadline may create compliance issues. Submit the required information to: contact.pharmacy@llr.sc.gov

For more information, visit the South Carolina Board of Pharmacy FAQ page.

503B Outsourcing Facility Regulatory Updates

The South Carolina Board of Pharmacy has also updated its 503B outsourcing facility regulations, with three key changes affecting licensing requirements, pharmacist-in-charge obligations, and notification requirements.

Licensing: Wholesale Distributor License No Longer Required

Previously, 503B outsourcing facilities operating in South Carolina were required to hold both an outsourcing facility permit and a wholesale distributor license. That dual requirement has been eliminated. Going forward, 503Bs are only required to hold the outsourcing facility permit.

Note that the South Carolina Board of Pharmacy is currently revising its applications to reflect this change. The applications may not be fully updated at the time of publication, but the regulatory change is already in effect. LighthouseAI confirmed this directly with the Board, which confirmed the applications are in the process of being updated.

One important exception: a 503B outsourcing facility that dispenses directly to patients pursuant to patient-specific prescriptions must also hold a separate pharmacy license in addition to the outsourcing facility permit.

Pharmacist-in-Charge Requirement

All 503B outsourcing facilities holding a South Carolina permit must have a South Carolina-licensed pharmacist-in-charge (PIC). LighthouseAI reached out directly to the South Carolina Board of Pharmacy for clarification on this requirement and received confirmation that, at this time, the South Carolina-licensed PIC requirement applies only to nonresident outsourcing facilities and nonresident non-dispensing pharmacies.

The compliance deadline for the PIC requirement is June 30, 2027. Facilities that do not currently have a South Carolina-licensed PIC should begin the process of identifying and onboarding a qualified pharmacist well in advance of that deadline.

Notification Requirements

503B outsourcing facilities must notify the South Carolina Board of Pharmacy within 30 days of any of the following:

• Disciplinary action issued by other states or the FDA
• FDA Form 483s or warning letters, and the facility's response
• Any recalls issued by the outsourcing facility

Permit holders and responsible pharmacists should review the full updated regulations to ensure ongoing compliance.

The official regulation changes are available here: South Carolina Board of Pharmacy Updated Regulations

What Organizations Should Do Now

For contract manufacturers, the October 5, 2026 deadline for existing permit holders to notify the Board is the most immediate priority. Missing this window will create compliance complications. The process is straightforward: send a brief email to the Board with your facility name, permit number, and a description of your business activities.

For 503B outsourcing facilities, the elimination of the wholesale distributor license requirement simplifies the licensing picture, but the new PIC requirement introduces a meaningful obligation that takes time to fulfill. Organizations that do not currently have a South Carolina-licensed pharmacist-in-charge should begin planning now rather than waiting until the June 30, 2027 deadline approaches.

Stay Ahead of Regulatory Change With LighthouseAI

Regulatory requirements across the pharmaceutical and medical device supply chain change constantly, and South Carolina is just one example of how quickly new obligations can emerge.

LighthouseAI's Selective Notifications deliver automated regulatory monitoring alerts tailored to your license portfolio, so your team is always informed of new and changing requirements across all 56 US jurisdictions before they affect your operations.

Never miss a new or changing state licensing requirement.

Request a Demo